Suppr超能文献

类风湿关节炎治疗的核心成分及其潜在机制。

Core Constituents of for Rheumatoid Arthritis Treatment and the Potential Mechanism.

作者信息

Qu Biao, Wang Shimin, Zhu Hailan, Yin Tianpeng, Zhou Renpeng, Hu Wei, Lu Chao

机构信息

Department of Clinical Pharmacology, The Second Hospital of Anhui Medical University, Hefei 230601, China.

Anhui Provincial Institute of Translational Medicine, Hefei 230032, China.

出版信息

ACS Omega. 2023 Jan 5;8(2):2586-2595. doi: 10.1021/acsomega.2c07094. eCollection 2023 Jan 17.

Abstract

PURPOSE

As a traditional herb product, the root of (Chinese name: Jin Quegen [JQG]) has been widely used in folk medicines for rheumatoid arthritis (RA) treatment. However, which herbal constituents exert a core pharmacological role in RA treatment remains a great challenge due to the multiple phytochemical constituents, targets, and pathways. In this work, we aimed to use a new strategy to explore the core herbal constituents and potential mechanisms of JQG against RA for the first time.

METHODS

A successively partitioned extract of JQG, bioactive partition screening in vitro and in vivo, qualitative analysis, bioinformatic analysis, molecular docking, and mechanism validation were used in this study. The partitioned extract was used to obtain the bioactive partition, while in vitro anti-inflammatory effects and in vivo anti-arthritis effects in adjuvant-induced arthritis (AIA) rats were applied to screen the bioactive partition with the best efficacy. Qualitative analysis was used to identify bioactive constituents. Bioinformatic analysis was used to explore the potential mechanism for RA treatment. Molecular docking and immunofluorescence were used to validate the underlying mechanism.

RESULTS

After successively partitioning extract and bioactive partition screening, ethyl acetate extract (EAE) yielded the best anti-inflammatory effects in vitro and in vivo among JQG extracts. By ultra-performance liquid chromatography (UPLC) coupled with Orbitrap mass spectrometry, a total of 58 constituents were identified in EAE, and 17 constituents were regarded as the core constituents based on their oral bioavailability and drug-like properties. The nuclear factor kappa B (NF-κB) signal pathway was screened as the core pathway of core constituents for RA treatment based on bioinformatic analysis, and the core constituents showed good ligand-receptor binding activity to NF-κB P65. In vitro study demonstrated that EAE could significantly reduce NF-κB P65 transfer from the cytoplasm to the nucleus.

CONCLUSION

Our study suggested that the therapeutic efficacy of JQG for RA treatment could be derived from negative regulation of the NF-κB pathway, and EAE of JQG could represent a promising herb product for RA treatment that deserves further development.

摘要

目的

作为一种传统草药产品,(中文名:金雀根[JQG])的根已被广泛用于民间治疗类风湿性关节炎(RA)的药物中。然而,由于其多种植物化学成分、靶点和途径,哪些草药成分在RA治疗中发挥核心药理作用仍然是一个巨大的挑战。在这项研究中,我们旨在首次采用一种新策略来探索JQG抗RA的核心草药成分和潜在机制。

方法

本研究采用JQG的连续分级提取物、体外和体内生物活性部位筛选、定性分析、生物信息学分析、分子对接和机制验证。分级提取物用于获得生物活性部位,同时采用体外抗炎作用和佐剂性关节炎(AIA)大鼠体内抗关节炎作用来筛选疗效最佳的生物活性部位。定性分析用于鉴定生物活性成分。生物信息学分析用于探索RA治疗的潜在机制。分子对接和免疫荧光用于验证潜在机制。

结果

经过连续分级提取物和生物活性部位筛选,乙酸乙酯提取物(EAE)在JQG提取物中表现出最佳的体外和体内抗炎作用。通过超高效液相色谱(UPLC)结合Orbitrap质谱,在EAE中总共鉴定出58种成分,基于其口服生物利用度和类药性质,17种成分被视为核心成分。基于生物信息学分析,核因子κB(NF-κB)信号通路被筛选为核心成分治疗RA的核心通路,核心成分对NF-κB P65表现出良好的配体-受体结合活性。体外研究表明,EAE可显著减少NF-κB P65从细胞质转移到细胞核。

结论

我们的研究表明,JQG治疗RA的疗效可能源于对NF-κB通路的负调控,JQG的EAE可能是一种有前途的用于RA治疗的草药产品,值得进一步开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff4f/9851025/7ce50aa587c6/ao2c07094_0002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验